Roger Strode Featured in Q&A on the Rise of Private Equity Investments in Cardiology

February 15, 2023 Cardiovascular Business

Foley & Lardner LLP Partner Roger Strode is featured in the Cardiovascular Business Q&A “What the rise of private equity investments in cardiology means for cardiologists and their patients.”

Strode explains the trend of recapitalization transactions in the health care space, what makes cardiology so appealing to investors right now, and the long-term strategy of and perspectives on these investments.

People

Roger D. Strode

Sectors

Health Care & Life Sciences

Practice Areas

Health Care

People

Roger D. Strode

rstrode@foley.com

Chicago 312.832.4565

Related News

View All Posts

July 11, 2025 In the News

Foley Attorneys Assess Critical IP Considerations for Emerging Medical Device Companies

Foley & Lardner LLP attorneys Shabbi Khan, Nate Beaver, Austin Kim, and Jeff Simon authored the Med Device Online article, "Critical Considerations For IP & Patents For Emerging Medical Device Companies."

July 11, 2025 In the News

David Morris Featured for Arrival to Foley's Salt Lake City Office

Foley & Lardner LLP partner David Morris is highlighted across legal press for his recent arrival to the firm.

July 10, 2025 In the News

Ann Marie Uetz Comments on Automotive Supply Chain Approach to Evolving Tariff Environment

Foley & Lardner LLP partner Ann Marie Uetz shared perspective from the automotive supply chain amid the evolving trade environment in the Crain's Detroit article, "Ford, Stellantis tighten terms on suppliers as tariff costs add up."